A neurochemical study of the novel antiepileptic drug retigabine in mouse brain

Sills, G. J., Rundfeldt, C., Butler, E., Forrest, G., Thompson, G. G. and Brodie, M. J. (2000) A neurochemical study of the novel antiepileptic drug retigabine in mouse brain. Pharmacological Research, 42(6), pp. 553-557. (doi:10.1006/phrs.2000.0738) (PMID:11058408)

Full text not currently available from Enlighten.

Abstract

The novel antiepileptic drug, retigabine, has been reported to have multiple mechanisms of action, including potentiation of γ -aminobutyric acid (GABA) and glutamate synthesis. We have investigated its effects on several GABA- and glutamate-related neurochemical parameters in mouse brain. Mice were administered retigabine either as a single dose or daily for 5 days. At 4 h after dosing, brains were removed and analysed for GABA, glutamate, and glutamine concentrations and for the activities of GABA-transaminase and glutamic acid decarboxylase. Single doses of retigabine significantly lowered brain concentrations of glutamate and glutamine. Repeated treatment significantly reduced the activity of GABA-transaminase. The drug was essentially without effect on all other parameters investigated. These results suggest that retigabine blocks GABA metabolism rather than enhancing GABA synthesis. In addition, the drug may also lower brain concentrations of the excitatory neurotransmitter glutamate and its precursor, glutamine. These effects may contribute to the antiepileptic action of retigabine.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Sills, Dr Graeme
Authors: Sills, G. J., Rundfeldt, C., Butler, E., Forrest, G., Thompson, G. G., and Brodie, M. J.
College/School:College of Medical Veterinary and Life Sciences > School of Life Sciences
Journal Name:Pharmacological Research
Publisher:Elsevier
ISSN:1043-6618
ISSN (Online):1096-1186

University Staff: Request a correction | Enlighten Editors: Update this record